You have 9 free searches left this month | for more free features.

Buprenorphine/Naloxone

Showing 1 - 25 of 812

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Opioid Use Disorder, Opioid Use, Opioid Abuse Trial in Boston (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • +4 more
  • buprenorphine/naloxone
  • Boston, Massachusetts
    Bicycle Health
Nov 30, 2022

Maternal Opioid Use Disorder, Opioid Exposed Infant Trial in Baltimore (fetal monitoring, Buprenorphine Naloxone, Methadone)

Recruiting
  • Maternal Opioid Use Disorder
  • Opioid Exposed Infant
  • fetal monitoring
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Dec 30, 2022

Drug Interaction, Analgesics, Opioid Trial in Richmond (Lemborexant, Placebo)

Recruiting
  • Drug Interaction
  • Analgesics, Opioid
  • Richmond, Virginia
    Virginia Commonwealth University
Nov 28, 2022

Opioid Use Disorder Trial in Bronx (buprenorphine-naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • Bronx, New York
    Montefiore Medical Center
Nov 28, 2022

Opioid Use Disorder Trial in Vancouver (Buprenorphine/naloxone, Hydromorphone)

Recruiting
  • Opioid Use Disorder
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Oct 5, 2022

Opioid Use Disorder Trial (ASP8062, Placebo ASP8062, buprenorphine/naloxone)

Withdrawn
  • Opioid Use Disorder
  • (no location specified)
Jul 3, 2022

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • buprenorphine/naloxone
  • (no location specified)
Jul 10, 2023

Opioid-use Disorder Trial in Memphis (Contingency Management, Brief Motivational Interviewing + Substance Free Activities +

Enrolling by invitation
  • Opioid-use Disorder
  • Contingency Management
  • Brief Motivational Interviewing + Substance Free Activities + Mindfulness
  • Memphis, Tennessee
    University of Tennessee Health Science Center
Jan 6, 2023

Opioid-use Disorder Trial in New Haven (CBT4CBT-Buprenorphine, Buprenorphine/naloxone)

Completed
  • Opioid-use Disorder
  • CBT4CBT-Buprenorphine
  • Buprenorphine/naloxone
  • New Haven, Connecticut
    Central Medical Unit of the APT Foundation
Jan 2, 2023

Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable

Not yet recruiting
  • Opioid-Related Disorders
  • +2 more
  • Injectable extended-release buprenorphine
  • Sublingual buprenorphine-naloxone
  • Garberville, California
  • +5 more
Aug 28, 2023

Opioid Dependence Fentanyl Trial in Harrisburg (Buprenorphine/naloxone)

Recruiting
  • Opioid Dependence Fentanyl
  • Buprenorphine/naloxone
  • Harrisburg, Pennsylvania
    The Pennsylvania Psychiatric Institute
Dec 1, 2022

Opioid Use Disorder Trial in Madison (Psilocybin with guided counseling)

Active, not recruiting
  • Opioid Use Disorder
  • Psilocybin with guided counseling
  • Madison, Wisconsin
    University of Wisconsin
Aug 19, 2022

Opioid-use Disorder Trial in New York (Buprenorphine Naloxone)

Recruiting
  • Opioid-use Disorder
  • Buprenorphine Naloxone
  • New York, New York
    NYU Langone
Aug 8, 2022

Opioid-use Disorder Trial in New York (Buprenorphine/naloxone, Placebo)

Recruiting
  • Opioid-use Disorder
  • Buprenorphine/naloxone
  • Placebo
  • New York, New York
    Stars/Nyspi
Aug 11, 2022

Opioid Use Disorder Trial in Overland Park (ASP8062, Placebo ASP8062, buprenorphine/naloxone)

Completed
  • Opioid Use Disorder
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Dec 14, 2021

Opioid-use Disorder Trial in Spokane (Reminders messages to improve adherence.)

Completed
  • Opioid-use Disorder
  • Reminders messages to improve adherence.
  • Spokane, Washington
    Washington State University
Jan 26, 2022

Patient Outcomes of Buprenorphine Microdosing

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • Buprenorphine/naloxone
  • (no location specified)
Mar 31, 2022

Addiction, Opioid Use, Substance Use Disorders Trial (Placebo, Auvelity)

Not yet recruiting
  • Addiction
  • +3 more
  • (no location specified)
Aug 3, 2023

Program-Combined With Warm Hand-Off Referral to Continued

Recruiting
  • Opioid Abuse
  • Implementation of the BINDeR-Tx service model
  • Salt Lake City, Utah
    University of Utah
Oct 11, 2023

Opioid Use Disorder Trial in Baltimore (Naloxone Nasal Spray)

Not yet recruiting
  • Opioid Use Disorder
  • Naloxone Nasal Spray
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Oct 13, 2023

HIV, Substance Related Disorders Trial in Bac Giang, Hanoi, Thanh Hoa (Buprenorphine/naloxone, Methadone Maintenance Therapy)

Completed
  • HIV
  • Substance Related Disorders
  • Buprenorphine/naloxone
  • Methadone Maintenance Therapy
  • Bac Giang, Vietnam
  • +5 more
Apr 25, 2022

Chronic Pain Trial in Minneapolis (Medication management, Non-pharmacological pain management, Buprenorphine-Naloxone)

Completed
  • Chronic Pain
  • Medication management
  • +2 more
  • Minneapolis, Minnesota
    Minneapolis VA Health Care System
Jan 12, 2023

Heroin Dependence Trial in New York (Buprenorphine/naloxone)

Terminated
  • Heroin Dependence
  • Buprenorphine/naloxone
  • New York, New York
    New York State Psychiatric Institute
Feb 4, 2022

Opioid Dependence Trial in New York (Buprenorphine Extended Release, Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic

Completed
  • Opioid Dependence
  • Buprenorphine Extended Release
  • Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)
  • New York, New York
    Bellevue Hospital Center
Dec 13, 2021

Opioid Use, Opioid Use Disorder, Risk Reduction Trial in Durham, Greensboro (Suboxone, Truvada, Mavyret)

Active, not recruiting
  • Opioid Use
  • +4 more
  • Durham, North Carolina
  • +1 more
Jan 19, 2023